2Seventy Bio Eulerpool News

2Seventy Bio Eulerpool News

2Seventy Bio Stock News

2Seventy Bio is being monitored by journalists and investors worldwide. We gather the latest 2Seventy Bio news here.

• July 29 ·

  Thefly.com
  2seventy Bio price target lowered by $1 at Morgan Stanley, here's why
• July 25 ·

  Stock Options Channel
  Commit To Buy 2seventy bio At $2.50, Earn 19.7% Annualized Using Options
• July 9 ·

  SeekingAlpha
  2seventy bio's Abecma: Compelling Investment In Multiple Myeloma Despite Competition
• July 4 ·

  Yahoo
  Broker Revenue Forecasts For 2seventy bio, Inc. (NASDAQ:TSVT) Are Surging Higher
• June 27 ·

  Seeking Alpha
  Novo Nordisk buys 2seventy bio’s Hemophilia A program
• June 26 ·

  Yahoo
  2seventy bio Announces Sale of Hemophilia A Candidate and MegaTAL In Vivo Gene Editing Technology to Novo Nordisk for up to $40 million
• June 26 ·

  TipRanks
  2seventy bio Strikes Strategic Gene Therapy Deal with Novo Nordisk
• June 26 ·

  Thefly.com
  2seventy Bio announces sale of Hemophilia A candidate for up to $40M
• June 14 ·

  Seeking Alpha
  EU to require additional cancer risk labeling on CAR T therapies
• June 11 ·

  TipRanks
  2seventy bio’s Board Elections and Financial Oversight Update